Literature DB >> 21678472

Sensory nerve induced inflammation contributes to heterotopic ossification.

Elizabeth Salisbury1, Eric Rodenberg, Corinne Sonnet, John Hipp, Francis H Gannon, Tegy J Vadakkan, Mary E Dickinson, Elizabeth A Olmsted-Davis, Alan R Davis.   

Abstract

Heterotopic ossification (HO), or bone formation in soft tissues, is often the result of traumatic injury. Much evidence has linked the release of BMPs (bone morphogenetic proteins) upon injury to this process. HO was once thought to be a rare occurrence, but recent statistics from the military suggest that as many as 60% of traumatic injuries, resulting from bomb blasts, have associated HO. In this study, we attempt to define the role of peripheral nerves in this process. Since BMP2 has been shown previously to induce release of the neuroinflammatory molecules, substance P (SP) and calcitonin gene related peptide (CGRP), from peripheral, sensory neurons, we examined this process in vivo. SP and CGRP are rapidly expressed upon delivery of BMP2 and remain elevated throughout bone formation. In animals lacking functional sensory neurons (TRPV1(-/-) ), BMP2-mediated increases in SP and CGRP were suppressed as compared to the normal animals, and HO was dramatically inhibited in these deficient mice, suggesting that neuroinflammation plays a functional role. Mast cells, known to be recruited by SP and CGRP, were elevated after BMP2 induction. These mast cells were localized to the nerve structures and underwent degranulation. When degranulation was inhibited using cromolyn, HO was again reduced significantly. Immunohistochemical analysis revealed nerves expressing the stem cell markers nanog and Klf4, as well as the osteoblast marker osterix, after BMP2 induction, in mice treated with cromolyn. The data collectively suggest that BMP2 can act directly on sensory neurons to induce neurogenic inflammation, resulting in nerve remodeling and the migration/release of osteogenic and other stem cells from the nerve. Further, blocking this process significantly reduces HO, suggesting that the stem cell population contributes to bone formation.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21678472      PMCID: PMC3329372          DOI: 10.1002/jcb.23225

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  67 in total

Review 1.  Cellular mechanisms of neurogenic inflammation.

Authors:  Jennelle Durnett Richardson; Michael R Vasko
Journal:  J Pharmacol Exp Ther       Date:  2002-09       Impact factor: 4.030

Review 2.  Neurogenic aspects of inflammation.

Authors:  Hans-Georg Schaible; Angela Del Rosso; Marco Matucci-Cerinic
Journal:  Rheum Dis Clin North Am       Date:  2005-02       Impact factor: 2.670

Review 3.  Molecular bases of the sympathetic regulation of bone mass.

Authors:  Shu Takeda; Gerard Karsenty
Journal:  Bone       Date:  2008-01-26       Impact factor: 4.398

Review 4.  Immunomodulatory mast cells: negative, as well as positive, regulators of immunity.

Authors:  Stephen J Galli; Michele Grimbaldeston; Mindy Tsai
Journal:  Nat Rev Immunol       Date:  2008-06       Impact factor: 53.106

5.  Hydrogel microsphere encapsulation of a cell-based gene therapy system increases cell survival of injected cells, transgene expression, and bone volume in a model of heterotopic ossification.

Authors:  Ronke M Olabisi; Zawaunyka W Lazard; Christy L Franco; Mary A Hall; Sun Kuk Kwon; Eva M Sevick-Muraca; John A Hipp; Alan R Davis; Elizabeth A Olmsted-Davis; Jennifer L West
Journal:  Tissue Eng Part A       Date:  2010-09-01       Impact factor: 3.845

6.  Disodium cromoglycate (FPL 670) ('Intal'): a specific inhibitor of reaginic antibody-antigen mechanisms.

Authors:  J S Cox
Journal:  Nature       Date:  1967-12-30       Impact factor: 49.962

7.  MSX2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors.

Authors:  Su-Li Cheng; Jian-Su Shao; Nichole Charlton-Kachigian; Arleen P Loewy; Dwight A Towler
Journal:  J Biol Chem       Date:  2003-08-18       Impact factor: 5.157

8.  Heterotopic ossification in high-energy wartime extremity injuries: prevalence and risk factors.

Authors:  Jonathan Agner Forsberg; Joseph M Pepek; Scott Wagner; Kevin Wilson; James Flint; Romney C Andersen; Doug Tadaki; Frederick A Gage; Alexander Stojadinovic; Eric A Elster
Journal:  J Bone Joint Surg Am       Date:  2009-05       Impact factor: 5.284

Review 9.  Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation.

Authors:  Catherine M Kolf; Elizabeth Cho; Rocky S Tuan
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

10.  Direct cell reprogramming is a stochastic process amenable to acceleration.

Authors:  Jacob Hanna; Krishanu Saha; Bernardo Pando; Jeroen van Zon; Christopher J Lengner; Menno P Creyghton; Alexander van Oudenaarden; Rudolf Jaenisch
Journal:  Nature       Date:  2009-11-08       Impact factor: 49.962

View more
  63 in total

Review 1.  Is heterotopic ossification getting nervous?: The role of the peripheral nervous system in heterotopic ossification.

Authors:  Eleanor L Davis; Alan R Davis; Zbigniew Gugala; Elizabeth A Olmsted-Davis
Journal:  Bone       Date:  2017-07-15       Impact factor: 4.398

2.  Apyrase as a novel therapeutic inhibitor of heterotopic ossification.

Authors:  Olin D Liang; Anthony M Reginato; Damian Medici
Journal:  Ann Transl Med       Date:  2015-05

3.  Delivery of siRNA silencing Runx2 using a multifunctional polymer-lipid nanoparticle inhibits osteogenesis in a cell culture model of heterotopic ossification.

Authors:  Swati Mishra; Asa D Vaughn; David I Devore; Charles M Roth
Journal:  Integr Biol (Camb)       Date:  2012-12       Impact factor: 2.192

Review 4.  The role of endothelial-mesenchymal transition in heterotopic ossification.

Authors:  Damian Medici; Bjorn R Olsen
Journal:  J Bone Miner Res       Date:  2012-07-02       Impact factor: 6.741

5.  Treatment of heterotopic ossification through remote ATP hydrolysis.

Authors:  Jonathan R Peterson; Sara De La Rosa; Oluwatobi Eboda; Katherine E Cilwa; Shailesh Agarwal; Steven R Buchman; Paul S Cederna; Chuanwu Xi; Michael D Morris; David N Herndon; Wenzhong Xiao; Ronald G Tompkins; Paul H Krebsbach; Stewart C Wang; Benjamin Levi
Journal:  Sci Transl Med       Date:  2014-09-24       Impact factor: 17.956

6.  Bioburden Increases Heterotopic Ossification Formation in an Established Rat Model.

Authors:  Gabriel J Pavey; Ammar T Qureshi; Donald N Hope; Rebecca L Pavlicek; Benjamin K Potter; Jonathan A Forsberg; Thomas A Davis
Journal:  Clin Orthop Relat Res       Date:  2015-09       Impact factor: 4.176

7.  Early Characterization of Blast-related Heterotopic Ossification in a Rat Model.

Authors:  Ammar T Qureshi; Erica K Crump; Gabriel J Pavey; Donald N Hope; Jonathan A Forsberg; Thomas A Davis
Journal:  Clin Orthop Relat Res       Date:  2015-09       Impact factor: 4.176

Review 8.  The immunological contribution to heterotopic ossification disorders.

Authors:  Michael R Convente; Haitao Wang; Robert J Pignolo; Frederick S Kaplan; Eileen M Shore
Journal:  Curr Osteoporos Rep       Date:  2015-04       Impact factor: 5.096

9.  Histologic identification of brown adipose and peripheral nerve involvement in human atherosclerotic vessels.

Authors:  Elizabeth Salisbury; John Hipp; Elizabeth A Olmsted-Davis; Alan R Davis; Michael H Heggeness; Francis H Gannon
Journal:  Hum Pathol       Date:  2012-06-27       Impact factor: 3.466

10.  RhoA mediates defective stem cell function and heterotopic ossification in dystrophic muscle of mice.

Authors:  Xiaodong Mu; Arvydas Usas; Ying Tang; Aiping Lu; Bing Wang; Kurt Weiss; Johnny Huard
Journal:  FASEB J       Date:  2013-05-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.